Carmel Capital Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,247
Closed -$87.1K 271
2023
Q3
$87.1K Buy
1,247
+296
+31% +$21K 0.04% 208
2023
Q2
$65.7K Sell
951
-494
-34% -$35.1K 0.03% 190
2023
Q1
$107K Sell
1,445
-1,080
-43% -$90.6K 0.06% 181
2022
Q4
$235K Sell
2,525
-134
-5% -$12.9K 0.16% 114
2022
Q3
$254K Hold
2,659
0.25% 92
2022
Q2
$246K Sell
2,659
-99
-4% -$9.66K 0.23% 94
2022
Q1
$279K Sell
2,758
-32
-1% -$3.36K 0.23% 89
2021
Q4
$288K Buy
+2,790
New +$258K 0.22% 91

Other funds holding CVS

Carmel Capital Partners's CVS Position: Q4 2023 in Review

Carmel Capital Partners sold out of CVS Health (CVS) in Q4 2023, closing a stake of 1,247 shares — an estimated $87.1K sold.

Carmel Capital Partners first reported a position in CVS in Q4 2021 and held it in 8 quarters. The position peaked at $288K in Q4 2021. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Carmel Capital Partners reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • Carmel Capital Partners sold 1,247 CVS Health shares in Q4 2023, an estimated $87.1K.
  • Carmel Capital Partners first reported a position in CVS Health in Q4 2021 and held it in 8 quarters.
  • Carmel Capital Partners's CVS Health position peaked at $288K in Q4 2021.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.